These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9655201)

  • 1. Intratympanic gentamicin in Meniere's disease.
    Kaasinen S; Pyykkö I; Ishizaki H; Aalto H
    Acta Otolaryngol; 1998 Jun; 118(3):294-8. PubMed ID: 9655201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin in bilateral Menière's disease.
    Pyykkö I; Ishizaki H; Kaasinen S; Aalto H
    Otolaryngol Head Neck Surg; 1994 Feb; 110(2):162-7. PubMed ID: 8108151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.
    Driscoll CL; Kasperbauer JL; Facer GW; Harner SG; Beatty CW
    Laryngoscope; 1997 Jan; 107(1):83-9. PubMed ID: 9001270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome.
    Harner SG; Driscoll CL; Facer GW; Beatty CW; McDonald TJ
    Otol Neurotol; 2001 Mar; 22(2):210-4. PubMed ID: 11300271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic gentamicin treatment for Meniere's disease.
    McFeely WJ; Singleton GT; Rodriguez FJ; Antonelli PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):589-96. PubMed ID: 9591855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease.
    Bodmer D; Morong S; Stewart C; Alexander A; Chen JM; Nedzelski JM
    Otol Neurotol; 2007 Dec; 28(8):1140-4. PubMed ID: 18084826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
    Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
    Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
    Liu YF; Renk E; Rauch SD; Xu HX
    Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
    Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK; Sandooram D; Prinsley PR
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.